Results 141 to 150 of about 5,425 (227)

RAS Inhibitor RMC‐7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT RAS mutations occur in patients with several types of vascular anomalies, but effective treatments remain limited. To address this need, we evaluated the RAS (ON) multi‐selective inhibitor RMC‐7977 in human endothelial cells (ECs) expressing the NRASQ61R mutation found in kaposiform lymphangiomatosis (KLA).
Sara Alharbi   +6 more
wiley   +1 more source

Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty. [PDF]

open access: yesCell Stem Cell
Ruiz JG   +24 more
europepmc   +1 more source

Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT. [PDF]

open access: yesPathophysiology
Saini S   +8 more
europepmc   +1 more source

Cirrhosis-associated intracranial shunting lesions: illustrative case. [PDF]

open access: yesJ Neurosurg Case Lessons
Haver J   +5 more
europepmc   +1 more source

Algorithms in Allergy: Hereditary Angioedema

open access: yes
Allergy, Volume 81, Issue 8, Page 3008-3012, August 2026.
Konrad Bork   +3 more
wiley   +1 more source

Perioperative Blood Biomarkers of Infectious and Non-Infectious Postoperative Pulmonary Complications: A Narrative Review. [PDF]

open access: yesJ Clin Med
Gigliotti S   +10 more
europepmc   +1 more source

Angiogenic Factors and Inflammatory Bowel Diseases. [PDF]

open access: yesBiomedicines
Li Z   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy